Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
Deloitte
Daiichi Sankyo
Accenture
US Department of Justice
Chubb
Colorcon
McKesson

Generated: June 20, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: icatibant acetate

« Back to Dashboard

icatibant acetate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Shire Orphan Therap FIRAZYR icatibant acetate INJECTABLE;SUBCUTANEOUS 022150 NDA Shire US Manufacturing Inc. N 54092-702-01
Shire Orphan Therap FIRAZYR icatibant acetate INJECTABLE;SUBCUTANEOUS 022150 NDA Shire US Manufacturing Inc. N 54092-702-02
Shire Orphan Therap FIRAZYR icatibant acetate INJECTABLE;SUBCUTANEOUS 022150 NDA Shire US Manufacturing Inc. N 54092-702-03
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Healthtrust
Mallinckrodt
Citi
Colorcon
Teva
Merck
Covington